Thanks Chuck,
Yes, it would be good if you could post it. And I did notice that it bounced back big . . . and I laughed at my own comments to you. I carefully chose Novartis for the long haul, and, since the timing seemed right in terms of PE, other technicals, and Europe, I bought a fair-sized chunk. Do you foresee long-term success, as I do, or are we gambling too much on "life science" potentialities, as opposed to making a pure pharmaceutical play with Merck or Pfizer, etc.? Time will tell, of course.
Tom |
